Go to:
Logótipo
Você está em: Start > Publications > View > Catechol-O-methyltransferase activity in psoriasis patients treated with psoralen plus ultraviolet A therapy
Map of Premises
Principal
Publication

Catechol-O-methyltransferase activity in psoriasis patients treated with psoralen plus ultraviolet A therapy

Title
Catechol-O-methyltransferase activity in psoriasis patients treated with psoralen plus ultraviolet A therapy
Type
Article in International Scientific Journal
Year
2013
Authors
souteiro, p
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
vieira-coelho, ma
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
serrao, mp
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
magina, s
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 29
Pages: 227-232
ISSN: 0905-4383
Publisher: Wiley-Blackwell
Scientific classification
FOS: Medical and Health sciences > Clinical medicine
Other information
Authenticus ID: P-006-753
Abstract (EN): Background Catechol-O-methyltransferase (COMT) activity is increased in patients with mild/moderate psoriasis. Narrowband ultraviolet B (nbUVB) phototherapy decreases COMT activity. However, the effect of psoralen plus ultraviolet A (PUVA) on this enzyme activity is unknown, and it remains to be clarified if the nbUVB-induced effect in COMT activity is related to clinical response. The aim of this study is to evaluate COMT activity in moderate/severe psoriasis and assess whether PUVA therapy modifies this activity. Methods An observational study was conducted on 18 patients with moderate/severe psoriasis and 13 matched controls. Patients were treated with PUVA twice weekly during 6 weeks, and they were evaluated for Psoriasis Area and Severity Index (PASI) and COMT activity before photochemotherapy, at the end of it and 4 weeks after stopping. Results Before PUVA therapy, S(soluble)-COMT activity was significantly (P < 0.05) higher in psoriasis patients than in controls. After photochemotherapy, no significant differences were found in S-COMT activity at all end points. Photochemotherapy significantly decreased PASI but COMT activity values remained higher than those of control population. Conclusion Psoriasis patients with moderate/severe disease present higher S-COMT activity than controls. Although a good clinical response was observed, PUVA therapy does not change S-COMT activity. This differential COMT effect of PUVA and nbUVB suggests a wavelength-specific regulation.
Language: English
Type (Professor's evaluation): Scientific
Contact: mimed07127@med.up.pt
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

SARS-CoV-2 pandemic and Vitamin D deficiency-A double trouble (2020)
Another Publication in an International Scientific Journal
Alpalhao, M; Pedro Pimentel-Nunes
Ultraviolet B radiation differentially modifies catechol-O-methyltransferase activity in keratinocytes and melanoma cells (2012)
Article in International Scientific Journal
magina, s; vieira-coelho, ma; serrao, mp; kosmus, c; moura, e; moura, d
Rilmenidine-induced photosensitivity reaction (1998)
Article in International Scientific Journal
Alberto Mota; Vasconcelos, C; Correia, TM; Barros, MA; Mesquita Guimaraes, J
Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-06 at 11:11:06 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book